Medisplint
Medisplint
As global aging populations demand higher quality of life, the Ankle Implant market has shifted from simple fusion techniques to sophisticated total ankle arthroplasty (TAA). Medisplint Orthopedic Instruments Co., Ltd., established in 2016, leverages 18,500㎡ of production space and advanced R&D to meet the rigorous CE and ISO 13485 standards required by international surgeons.
China has transitioned from a component supplier to a leader in Integrated Orthopedic Solutions. Our facility employs 42 dedicated quality inspectors and 85 R&D specialists, ensuring that every implant—from titanium alloy constructs to high-precision fixation screws—undergoes rigorous fatigue and performance testing. We provide the "Information Gain" for distributors by offering transparent supply chain documentation and validated clinical performance data.
Modern hospitals are moving toward modular, patient-specific surgical kits. Our collaborative model supports 1,200+ partners globally, providing OEM/ODM flexibility. Whether it is sports medicine clinics in Europe or trauma centers in the Middle East, our implants are designed for rapid osseointegration and long-term stability.
Q: What certifications do Medisplint products hold?
A: All our orthopedic implants are manufactured in compliance with ISO 13485 quality management systems and hold necessary CE compliance for international markets.
Q: Do you offer customized OEM manufacturing?
A: Yes, with 85 engineering specialists, we provide full-cycle OEM/ODM services, including private labeling and design modifications.
Q: What is your production capacity?
A: We operate a 18,500㎡ facility with over 1,200 supply chain partners, ensuring high-volume, reliable production timelines for global hospitals and distributors.
